GLX Analytix Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.3M

  • Investors
  • 7

GLX Analytix General Information

Description

Operator of a personalized medicine platform designed to improve patient care through advanced diagnostic and monitoring capabilities. The company offers a combination of vascular biology insights, AI-driven analysis, and blood-based biomarkers, enabling clinicians treating neuropsychiatric, neurodegenerative, and autoimmune conditions to detect disease earlier, monitor progression more accurately, and guide treatment with greater precision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
Primary Industry
Other Healthcare
Corporate Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark

GLX Analytix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GLX Analytix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 23-Oct-2024 $2.3M Completed Generating Revenue
6. Secondary Transaction - Private 18-Jan-2023 Completed Generating Revenue
5. Early Stage VC (Series 1) 11-May-2022 Completed Generating Revenue
4. Early Stage VC 05-May-2022 Completed Generating Revenue
3. Early Stage VC 01-Mar-2021 Completed Product Development
2. Early Stage VC 15-Feb-2019 $457K $457K Completed Startup
1. University Spin-Out Completed Startup
To view GLX Analytix’s complete valuation and funding history, request access »

GLX Analytix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 7,000 $61.51 $61.51 1x $61.51 13.33%
To view GLX Analytix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

GLX Analytix Patents

GLX Analytix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025262337-A1 Methods and kits for identifying neurological diseases and conditions Pending 21-Jun-2024
CA-3112009-A1 Glx-derived molecule detection Pending 12-Sep-2018
EP-3623816-A1 Glx-derived molecule detection Inactive 12-Sep-2018
JP-2024156718-A Glx-derived molecule detection Pending 12-Sep-2018
WO-2020053355-A2 Glx-derived molecule detection Inactive 12-Sep-2018 G01N33/6893
To view GLX Analytix’s complete patent history, request access »

GLX Analytix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GLX Analytix Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital Minority
Labcorp Venture Fund Corporate Venture Capital Minority
Angel (individual) Minority
Denmark's Export and Investment Fund Venture Capital Minority
DigitalDx Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

GLX Analytix FAQs

  • When was GLX Analytix founded?

    GLX Analytix was founded in 2018.

  • Where is GLX Analytix headquartered?

    GLX Analytix is headquartered in Copenhagen, Denmark.

  • What is the size of GLX Analytix?

    GLX Analytix has 4 total employees.

  • What industry is GLX Analytix in?

    GLX Analytix’s primary industry is Other Healthcare.

  • Is GLX Analytix a private or public company?

    GLX Analytix is a Private company.

  • What is GLX Analytix’s current revenue?

    The current revenue for GLX Analytix is .

  • How much funding has GLX Analytix raised over time?

    GLX Analytix has raised $4.81M.

  • Who are GLX Analytix’s investors?

    Alzheimers Drug Discovery Foundation, Labcorp Venture Fund, , Denmark's Export and Investment Fund, and DigitalDx Ventures are 5 of 7 investors who have invested in GLX Analytix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process